Cargando…
Combined treatments in hepatocellular carcinoma: Time to put them in the guidelines?
The time for battling cancer has never been more suitable than nowadays and fortunately against hepatocellular carcinoma (HCC) we do have a far-reaching arsenal. Moreover, because liver cancer comprises a plethora of stages-from very early to advanced disease and with many treatment options–from sur...
Autores principales: | Sparchez, Zeno, Radu, Pompilia, Bartos, Adrian, Nenu, Iuliana, Craciun, Rares, Mocan, Tudor, Horhat, Adelina, Spârchez, Mihaela, Dufour, Jean-François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713312/ https://www.ncbi.nlm.nih.gov/pubmed/35070032 http://dx.doi.org/10.4251/wjgo.v13.i12.1896 |
Ejemplares similares
-
Ultrasound or Sectional Imaging Techniques as Screening Tools for Hepatocellular Carcinoma: Fall Forward or Move Forward?
por: Sparchez, Zeno, et al.
Publicado: (2021) -
Refining Liver Biopsy in Hepatocellular Carcinoma: An In-Depth Exploration of Shifting Diagnostic and Therapeutic Applications
por: Spârchez, Zeno, et al.
Publicado: (2023) -
Endoscopic or percutaneous biliary drainage in hilar cholangiocarcinoma: When and how?
por: Mocan, Tudor, et al.
Publicado: (2021) -
Novel approaches in search for biomarkers of cholangiocarcinoma
por: Mocan, Lavinia-Patricia, et al.
Publicado: (2022) -
Viscoelastic tests in liver disease: where do we stand now?
por: Buliarca, Alina, et al.
Publicado: (2021)